Session Description :
This session is designed to teach the audience concerning newer approaches for the diagnosis and sub-phenotyping of kidney diseases and the latest developments in therapy.
Learning Objectives:
Understand the challenges and opportunities for diagnosing and treating rare diseases in developing countries. Review the latest developments in targeting the complement pathway for treatment of kidney disease. Understand how the revolution in CAR-T therapies is affecting the treatment of refractory lupus nephritis.
| Time | Session |
|---|
|
9 a.m.
9:18 a.m.
|
Deciphering the IGAN Cell Atlas
|
|
9:18 a.m.
9:36 a.m.
|
Complement-mediated Kidney Diseases in the Era of Complement Inhibitors
MarinaVivarelli
Speaker
marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital
|
|
9:36 a.m.
9:54 a.m.
|
CART-T
|
|
9:54 a.m.
10:15 a.m.
|
New Targets to Reduce the Burden of Rare Kidney Diseases
|
|
10:15 a.m.
10:30 a.m.
|
Q and A
|